CNS Neuroscience & Therapeutics

Our screening does not flag CNS Neuroscience & Therapeutics. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in DOAJ, Scopus, Web of Science, PubMed, which is a positive signal.

Per our venue index, CNS Neuroscience & Therapeutics appears in: DOAJ, Scopus, Web of Science, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.

Papers in CNS Neuroscience & Therapeutics are cited about 4.8 times each within two years of publication, and Scimago places it in Q1, with an h-index of 117. This is not a Clarivate Journal Impact Factor — we neither compute nor license that metric — and a citation rate is a property of a field as much as of a journal.

Our index records its access status as "gold". Where this is derived from publisher-level signals rather than works-level data it is a heuristic, so confirm on the journal's own site — particularly if an article processing charge matters to you.